References
- Lewis, C, O’Donnell, A, McQuaid, S and James, J. 2015. Contribution of biobanks to care services. Cancer Nursing Practice, 14(9): 21–24. DOI: 10.7748/cnp.14.9.21.s19
- Lewis, C, McQuaid, S, Hamilton, P, Salto-Tellez, M, McArt, D and James, J. 2016. Building a ‘Repository of Science’: The importance of integrating biobanks within molecular pathology programmes. European Journal of Cancer, 67: 191–199. DOI: 10.1016/j.ejca.2016.08.009
- Jain, S, Lyons, C, Walker, S, McQuaid, S, Hynes, S, Mitchell, D, et al. 2017. Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy. Annals of Oncology, 29(1): 215–222. DOI: 10.1093/annonc/mdx637
- Buckley, N, Boyle, D, McArt, D, Irwin, G, Harkin, D, Lioe, T et al. 2015. Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention. Oncotarget, 6(41). DOI: 10.18632/oncotarget.6525
- Alvi, M, McArt, D, Kelly, P, Fuchs, M, Alderdice, M, McCabe, C et al. 2015. Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility. Oncotarget, 6(25). DOI: 10.18632/oncotarget.4576
- Bingham, V, McIlreavey, L, Greene, C, O’Doherty, E, Clarke, R, Craig, S et al. 2017. RNAscope in situ hybridization confirms mRNA integrity in formalin-fixed, paraffin-embedded cancer tissue samples. Oncotarget, 8: 93392–93403 DOI: 10.18632/oncotarget.21851
- Mulligan, J, Hill, L, Deharo, S, Irwin, G, Boyle, D, Keating, K et al. 2014. Identification and Validation of an Anthracycline/Cyclophosphamide–Based Chemotherapy Response Assay in Breast Cancer. JNCI: Journal of the National Cancer Institute, 106(1). DOI: 10.1093/jnci/djt335